Berlin: Bayer has received accelerated approval from the U.S. Food and Drug Administration (FDA) for HYRNUO ...

The FDA has given accelerated approval to Bayer for oral HER2 tyrosine kinase inhibitor sevabertinib as a second-line treatment for advanced HER2-mutant non-small cell lung cancer (NSCLC), allowing it ...

Bayer’s Hyrnuo gets US FDA accelerated approval to treat patients with previously treated advanced HER2-mutant NSCLC: Berlin Friday, November 21, 2025, 11:00 Hrs [IST] Following ...

In 2024, the U.S. FDA granted HYRNUO Breakthrough Therapy designation for the treatment of adult patients with unresectable or metastatic NSCLC whose tumors have activating HER2 (ERBB2) mutations, and ...

Liverpool boss Arne Slot is saying some worrying things as he tries to reverse the team's horrendous form. His job is right ...

The latest, third generation Audi Q5 family has just made its debut in Singapore. This is the first SUV from the brand to ...

Pep Guardiola has never coached a European competition game below the Champions League level and on Tuesday leads Manchester ...

Bayern Munich star Harry Kane does not need an advanced scouting report to know that Arsenal is going to be a handful to deal ...

Shares of Regeneron Pharmaceuticals REGN have gained 21.5% year to date compared with the industry’s growth of 10.2%. The stock has also outperformed the sector and the S&P 500 Index during this time ...

Per Clinic is a boutique-style hair transplant provider, focusing on a limited number of patients per day. Like many modern Turkish clinics, it typically works with follicular unit (FUE) and direct ...

Harry Kane made the difference yet again with two late goals as England beat Albania 2-0 in their final World Cup qualifier ...

Q3 2025 Earnings Call Transcript November 20, 2025 Evogene Ltd. beats earnings expectations. Reported EPS is $-0.31, ...